{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:49:18Z","timestamp":1792594158438,"version":"4.5.0"},"reference-count":120,"publisher":"FapUNIFESP (SciELO)","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"DOI":"10.1590\/abd1806-4841.20199011","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T15:33:24Z","timestamp":1564241604000},"page":"264-278","source":"Crossref","is-referenced-by-count":147,"title":["Pemphigus vulgaris"],"prefix":"10.1590","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0736-4790","authenticated-orcid":false,"given":"Adriana Maria","family":"Porro","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8145-268X","authenticated-orcid":false,"given":"Camila Arai","family":"Seque","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0217-6643","authenticated-orcid":false,"given":"Maria Carolina Corsi","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3340-4074","authenticated-orcid":false,"given":"Milvia Maria Sim\u00f5es e Silva","family":"Enokihara","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2019,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2340\/00015555-2611","article-title":"Mortality and cause of death in Israeli patients with pemphigus","volume":"97","author":"Kridin K","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/bjd.14463","article-title":"Comorbidities and inpatient mortality for pemphigus in the USA","volume":"174","author":"Hsu DY","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00281-015-0541-1","article-title":"Immune response in pemphigus and beyond: progresses and emerging concepts","volume":"38","author":"Di Zenzo G","year":"2016","journal-title":"Semin Immunopathol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1172\/JCI5252","article-title":"Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris","volume":"103","author":"Mahoney MG","year":"1999","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1365-2230.2011.04092.x","article-title":"The pathogenic role of autoantibodies in pemphigus vulgaris","volume":"36","author":"Pan M","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clindermatol.2011.01.013","article-title":"Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis)","volume":"29","author":"Joly P","year":"2011","journal-title":"Clin Dermatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/exd.12229","article-title":"Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris","volume":"22","author":"Amber KT","year":"2013","journal-title":"Exp Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2016.06.055","article-title":"Remarkable differences in the epidemiology of pemphigus among two ethnic populations in the same geographic region","volume":"75","author":"Kridin K","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"ref9","series-title":"Dermatology","first-page":"494","volume-title":"Pemphigus","author":"Amagai M","year":"2018","edition":"4th ed"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/ijd.13714","article-title":"Geographical foci and epidemiological changes of pemphigus vulgaris in four decades in Southeastern Brazil","volume":"56","author":"Celere BS","year":"2017","journal-title":"Int J Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz M","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/jdv.14886","article-title":"Influence of cigarette smoking on pemphigus - a systematic review and pooled analysis of the literature","volume":"32","author":"Lai O","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1590\/abd1806-4841.20142930","article-title":"Prevalence of metabolic syndrome and its components in a Brazilian sample of pemphigus patients","volume":"89","author":"Ambiel MV","year":"2014","journal-title":"An Bras Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjd.13433","article-title":"Identification of a new disease cluster of pemphigus vulgaris with autoimmune thyroid disease, rheumatoid arthritis and type I diabetes","volume":"172","author":"Parameswaran A","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4103\/0019-5154.87151","article-title":"Mental health in patients with pemphigus: an issue to worth consideration","volume":"56","author":"Arbabi M","year":"2011","journal-title":"Indian J Dermatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono A","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/jid.2014.547","article-title":"Malignancies in pemphigus and pemphigoid diseases","volume":"135","author":"Schulze F","year":"2015","journal-title":"J Invest Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaad.2017.11.039","article-title":"Pemphigus and hematologic malignancies: A population-based study of 11,859 patients","volume":"78","author":"Kridin K","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","article-title":"Risks of myeloid malignancies in patients with autoimmune conditions","volume":"100","author":"Anderson LA","year":"2009","journal-title":"Br J Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0923-1811(94)00371-K","article-title":"The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan","volume":"9","author":"Ogawa H","year":"1995","journal-title":"J Dermatol Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jamadermatol.2017.6334","article-title":"Coexistent Solid Malignancies in Pemphigus: A Population-Based Study","volume":"154","author":"Kridin K","year":"2018","journal-title":"JAMA Dermatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1083\/jcb.122.2.409","article-title":"Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes","volume":"122","author":"K\u00e1rp\u00e1ti S","year":"1993","journal-title":"J Cell Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1083\/jcb.201008173","article-title":"Evolution: structural and functional diversity of cadherin at the adherens junction","volume":"193","author":"Oda H","year":"2011","journal-title":"J Cell Biol"},{"key":"ref24","first-page":"1","article-title":"Identification of desmoglein, a constitutive desmosomal glycoprotein, as a member of the cadherin family of cell adhesion molecules","volume":"53","author":"Koch PJ","year":"1990","journal-title":"Eur J Cell Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/1523-1747.ep12343081","article-title":"Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients","volume":"106","author":"Amagai M","year":"1996","journal-title":"J Invest Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ajpath.2011.04.015","article-title":"Pathogenic relevance of IgG and IgM antibodies against desmoglein 3 in blister formation in pemphigus vulgaris","volume":"179","author":"Tsunoda K","year":"2011","journal-title":"Am J Pathol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/ijd.13577","article-title":"Study of the association between human leukocyte antigens (HLA) and pemphigus vulgaris in Brazilian patients","volume":"56","author":"Gil JM","year":"2017","journal-title":"Int J Dermatol"},{"key":"ref28","series-title":"Rook\u2019s Textbook of Dermatology","first-page":"40.1","volume-title":"Immunobullous Diseases","volume":"2","author":"Wojnarowska F","year":"2010","edition":"8th ed"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.autrev.2015.06.005","article-title":"Oral mucosal manifestations of autoimmune skin diseases","volume":"14","author":"Mustafa MB","year":"2015","journal-title":"Autoimmun Rev"},{"key":"ref30","first-page":"367","article-title":"Oral Pemphigus Vulgaris: Case Report","volume":"25","author":"Arpita R","year":"2015","journal-title":"Ethiop J Health Sci"},{"key":"ref31","series-title":"Dermatology","first-page":"469","volume-title":"Pemphigus","volume":"1","author":"Amagai M","year":"2012","edition":"3rd ed"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.det.2011.03.004","article-title":"Diagnosis and clinical features of pemphigus vulgaris","volume":"29","author":"Venugopal SS","year":"2011","journal-title":"Dermatol Clin"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6154397","article-title":"The Significance of Scalp Involvement in Pemphigus: A Literature Review","volume":"2018","author":"Sar-Pomian M","year":"2018","journal-title":"Biomed Res Int"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/0019-5154.123483","article-title":"Eponymous Dermatological Signs in Bullous Dermatoses","volume":"59","author":"Ganapati S","year":"2014","journal-title":"Indian J Dermatol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jaad.2005.01.106","article-title":"Cutaneous type pemphigus vulgaris: a rare clinical phenotype of pemphigus","volume":"52","author":"Yoshida K","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1067\/mjd.2000.106236","article-title":"Nail involvement in pemphigus vulgaris","volume":"43","author":"Engineer L","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/ced.12629","article-title":"Recurrent angular cheilitis in a patient with mucocutaneous pemphigus vulgaris","volume":"40","author":"Caetano Lde V","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.clindermatol.2015.04.011","article-title":"Pemphigus vegetans of the folds (intertriginous areas)","volume":"33","author":"Ruocco V","year":"2015","journal-title":"Clin Dermatol"},{"key":"ref39","first-page":"130","article-title":"Neonatal pemphigus in an infant born to a mother with pemphigus vulgaris: a case report","volume":"37","author":"Carvalho AA","year":"2019","journal-title":"Rev Paul Pediatr"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1346-8138.2008.00515.x","article-title":"Neonatal pemphigus vulgaris","volume":"35","author":"Gushi M","year":"2008","journal-title":"J Dermatol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/ddg.13637","article-title":"Diagnosis of autoimmune bullous diseases","volume":"16","author":"van Beek N","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref42","first-page":"490","article-title":"Direct and indirect immunofluorescence","volume":"85","author":"Aoki V","year":"2010","journal-title":"An Bras Dermatol"},{"key":"ref43","series-title":"Dermatologia","first-page":"127","volume-title":"Imunofluoresc\u00eancia, immunoblotting e imunoprecipita\u00e7\u00e3o","author":"Aoki V","year":"2007","edition":"3rd ed"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3181\/00379727-117-29622","article-title":"Demonstration of skin antibodies in Sera of Pemphigus Vulgaris Patients by Indirect Immunofluorescent Staining","volume":"117","author":"Beutner EH","year":"1964","journal-title":"Proc Soc Exp Biol Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/1523-1747.ep12337524","article-title":"Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles","volume":"109","author":"Ding X","year":"1997","journal-title":"J Invest Dermatol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1073\/pnas.92.11.5239","article-title":"Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity","volume":"92","author":"Bhol K","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","series-title":"Manual de Imuno-histoqu\u00edmic","author":"Alves VAF","year":"1999"},{"key":"ref48","series-title":"Diagnostic Immunohistochemistry: theranostic and genomic applications","first-page":"18","author":"Dabbs D","year":"2014","edition":"4th ed"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi C","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clindermatol.2011.03.013","article-title":"Immunosuppressive therapy for autoimmune bullous diseases","volume":"30","author":"Meurer M","year":"2012","journal-title":"Clin Dermatol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","article-title":"The adjuvant therapy of pemphigus. An update","volume":"132","author":"Bystryn JC","year":"1996","journal-title":"Arch Dermatol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/jdv.12772","article-title":"Pemphigus. S2 guideline for diagnosis and treatment-guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)","volume":"29","author":"Hertl M","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.intimp.2017.10.027","article-title":"Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?","volume":"53","author":"Tavakolpour S","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clindermatol.2013.01.005","article-title":"Pemphigus: Associations and management guidelines: Facts and controversies","volume":"31","author":"Ruocco E","year":"2013","journal-title":"Clin Dermatol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/bjd.15930","article-title":"British Association of Dermatologists\u2019 guidelines for the management of pemphigus vulgaris 2017","volume":"177","author":"Harman KE","year":"2017","journal-title":"Br J Dermatol"},{"key":"ref56","first-page":"329","article-title":"Pulse therapy and its modifications in pemphigus: a six year study","volume":"69","author":"Rao PN","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0190-9622(82)70111-2","article-title":"Death in pemphigus","volume":"7","author":"Ahmed AR","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.det.2011.07.001","article-title":"Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus","volume":"29","author":"Frew JW","year":"2011","journal-title":"Dermatol Clin"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jaad.2015.04.038","article-title":"The role of adjuvant therapy in pemphigus: A systematic review and meta-analysis","volume":"73","author":"Atzmony L","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1172\/JCI200318384","article-title":"Azathioprine: old drug, new actions","volume":"111","author":"Maltzman JS","year":"2003","journal-title":"J Clin Invest"},{"key":"ref61","first-page":"1285","article-title":"Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris","volume":"27","author":"Chams-Davatchi C","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1468-3083.2010.03753.x","article-title":"High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study","volume":"25","author":"Chaidemenos G","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/1346-8138.12486","article-title":"Japanese guidelines for the management of pemphigus","volume":"41","author":"Amagai M","year":"2014","journal-title":"J Dermatol"},{"key":"ref64","first-page":"353","article-title":"Mycophenolate mofetil-a new atheropreventive drug?","volume":"71","author":"Olejarz W","year":"2014","journal-title":"Acta Pol Pharm"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s12325-016-0343-4","article-title":"Management of Pemphigus Vulgaris","volume":"33","author":"Cholera M","year":"2016","journal-title":"Adv Ther"},{"key":"ref66","first-page":"210","article-title":"Mycophenolate mofetil as a first-line steroid sparing agent in the treatment of pemphigus vulgaris","volume":"12","author":"Vyas N","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jaad.2010.04.039","article-title":"A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus","volume":"64","author":"Martin LK","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","article-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo controlled trial","volume":"130","author":"Beissert S","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immuneglobulin","volume":"355","author":"Ahmed AR","year":"2006","journal-title":"N Engl J Med"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1038\/jid.2008.172","article-title":"Rituximab exerts a dual effect in pemphigus vulgaris","volume":"128","author":"Eming R","year":"2008","journal-title":"J Invest Dermatol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jaad.2015.11.008","article-title":"Future therapies for pemphigus vulgaris: Rituximab and beyond","volume":"74","author":"Huang A","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2340\/00015555-2116","article-title":"Efficacy of rituximab for pemphigus: a systematic review and meta-analysis of different regimens","volume":"95","author":"Wang HH","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly P","year":"2017","journal-title":"Lancet"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jamadermatol.2014.2421","article-title":"First-line treatment of pemphigus vulgaris with a combination of rituximab and high-potency topical corticosteroids","volume":"151","author":"Ingen-Housz-Oro S","year":"2015","journal-title":"JAMA Dermatol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.intimp.2017.11.005","article-title":"Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review","volume":"54","author":"Tavakolpour S","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaad.2011.11.007","article-title":"Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up","volume":"67","author":"Cianchini G","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jamadermatol.2013.6739","article-title":"Durable remission of pemphigus with a fixed-dose rituximab protocol","volume":"150","author":"Heelan K","year":"2014","journal-title":"JAMA Dermatol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/bjd.12972","article-title":"Clinical and immunological outcomes of high and low dose rituximab treatments in pemphigus patients:a randomized comparative observer blinded study","volume":"170","author":"Kanwar AJ","year":"2014","journal-title":"Br J Dermatol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/jdv.12678","article-title":"An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab","volume":"29","author":"Amber KT","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly P","year":"2007","journal-title":"N Engl J Med"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/0378-6323.136832","article-title":"Intermediate doses of rituximab used as adjuvant therapy in refractory pemphigus","volume":"80","author":"Londhe PJ","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immuneglobulin","volume":"355","author":"Ahmed AR","year":"2006","journal-title":"N Engl J Med"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.intimp.2016.02.013","article-title":"First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: preliminary retrospective study with a seven year follow-up","volume":"34","author":"Ahmed AR","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1365-2133.2011.10732.x","article-title":"Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris","volume":"166","author":"Behzad M","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.jaad.2006.07.019","article-title":"Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2)","volume":"56","author":"Graves JE","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"ref86","first-page":"1031","article-title":"Adjuvant rituximab therapy of pemphigus: a single-center experience with 31 patients","volume":"148","author":"Lunardon L","year":"2012","journal-title":"Arch Arch Dermatol"},{"key":"ref87","article-title":"Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts","author":"Murrell DF","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/bjd.12972","article-title":"Clinical and immunological outcomes of high and low dose rituximab treatments in pemphigus patients: a randomized comparative observer blinded study","volume":"170","author":"Kanwar AJ","year":"2014","journal-title":"Br J Dermatol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jamadermatol.2013.6739","article-title":"Durable remission of pemphigus with a fixed-dose rituximab protocol","volume":"150","author":"Heelan K","year":"2014","journal-title":"JAMA Dermatol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaad.2012.08.010","article-title":"Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients","volume":"68","author":"Leshem YA","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/jdv.12772","article-title":"Pemphigus. S2 guideline for diagnosis and treatment-guided by the European dermatology forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)","volume":"29","author":"Hertl M","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2230.2009.03450.x","article-title":"Corticosteroid \/cyclophosphamide pulse treatment in south African patients with pemphigus","volume":"35","author":"Shaik F","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-015-0353-6","article-title":"Pemphigus Vulgaris: An Evidence-Based Treatment Update","volume":"75","author":"Zhao CY","year":"2015","journal-title":"Drugs"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/ced.12073","article-title":"Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris","volume":"38","author":"Sharma VK","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1610-0378.2005.04747.x","article-title":"Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study","volume":"3","author":"Rose E","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4103\/0378-6323.55390","article-title":"Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris","volume":"75","author":"Sethy PK","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/0378-6323.104672","article-title":"Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study","volume":"79","author":"Parmar NV","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2133.2009.09246.x","article-title":"Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid","volume":"161","author":"G\u00fcrcan HM","year":"2009","journal-title":"Br J Dermatol"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1684\/ejd.2011.1611","article-title":"Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris","volume":"22","author":"Baum S","year":"2012","journal-title":"Eur J Dermatol"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/bjd.12474","article-title":"Methotrexate in the treatment of pemphigus vulgaris: experience in 23 patients","volume":"169","author":"Tran KD","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1684\/ejd.2011.1611","article-title":"Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris","volume":"22","author":"Baum S","year":"2012","journal-title":"Eur J Dermatol"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/11310740-000000000-00000","article-title":"Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data","volume":"10","author":"G\u00fcrcan HM","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1159\/000448028","article-title":"Efficacy of Dapsone in the treatment of pemphigus vulgaris: a single-center case study","volume":"232","author":"Baum S","year":"2016","journal-title":"Dermatology"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00128071-200708020-00004","article-title":"Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris","volume":"8","author":"Olszewska M","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.transci.2016.12.017","article-title":"Mechanisms of action of intravenous immunoglobulin","volume":"56","author":"Chaigne B","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/ajd.12422","article-title":"IVIG therapy in pemphigus vulgaris has corticosteroid-sparing and immunomodulatory effects","volume":"57","author":"Svecova D","year":"2016","journal-title":"Australas J Dermatol"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","author":"Amagai M","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1684\/ejd.2014.2483","article-title":"Pemphigus vulgaris: approach to treatment","volume":"25","author":"Sinha AA","year":"2015","journal-title":"Eur J Dermatol"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000090659","article-title":"Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption","volume":"212","author":"Eming R","year":"2006","journal-title":"Dermatology"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1744-9987.2012.01075.x","article-title":"Immunoadsorption in dermatology","volume":"16","author":"Meyersburg D","year":"2012","journal-title":"Ther Apher Dial"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2230.2004.01499.x","article-title":"Beneficial effects of topical tacrolimus on recalcitrant erosions of pemphigus vulgaris","volume":"29","author":"Gach JE","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell DF","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archderm.144.5.682","article-title":"Kinetics of response to conventional treatment in patients with pemphigus vulgaris","volume":"144","author":"Czernik A","year":"2008","journal-title":"Arch Dermatol"},{"key":"ref114","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006263.pub2","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus","author":"Martin LK","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0190-9622(00)90213-5","article-title":"Patterns of remission in pemphigus vulgaris","volume":"42","author":"Herbst A","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaad.2013.05.016","article-title":"Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids","volume":"69","author":"Almugairen N","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus group: overview, epidemiology, mortality, and comorbidities","volume":"66","author":"Kridin K","year":"2018","journal-title":"Immunol Res"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-017-8662-z","article-title":"Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches","volume":"54","author":"Pollmann R","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.clindermatol.2015.11.006","article-title":"Autoimmune bullous diseases with skin and eye involvement: Cicatricial pemphigoid.pemphigus vulgaris.and pemphigus paraneoplastica","volume":"34","author":"Broussard KC","year":"2016","journal-title":"Clin Dermatol"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40257-014-0101-9","article-title":"Treatment of Pemphigus Vulgaris and Pemphigus Foliaceus: A Systematic Review and Meta-Analysis","volume":"15","author":"Atzmony L","year":"2014","journal-title":"Am J Clin Dermatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v94n3\/0365-0596-abd-94-03-0264.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:00:46Z","timestamp":1747652446000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962019000300264&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":120,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["S0365-05962019000300264"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20199011","relation":{},"ISSN":["1806-4841","0365-0596"],"issn-type":[{"value":"1806-4841","type":"electronic"},{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}